Global Engineered T Cells Market Insights, Forecast to 2025

SKU ID : QYR-14040618 | Publishing Date : 01-Apr-2019 | No. of pages : 111

Detailed TOC of Global Engineered T Cells Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage
    1.1  Engineered T Cells Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Engineered T Cells Market Size Growth Rate by Product
        1.4.2 Tumor Infiltrating Lymphocytes
        1.4.3 T Cell Receptor {TCR}
        1.4.4 Chimeric Antigen Receptor (CAR)
    1.5 Market by End User
        1.5.1 Global Engineered T Cells Market Size Growth Rate by End User
        1.5.2 Hospitals
        1.5.3 Cancer Research Centers
        1.5.4 Clinics
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Engineered T Cells Market Size
        2.1.1 Global Engineered T Cells Revenue 2014-2025
        2.1.2 Global Engineered T Cells Sales 2014-2025
    2.2 Engineered T Cells Growth Rate by Regions
        2.2.1 Global Engineered T Cells Sales by Regions
        2.2.2 Global Engineered T Cells Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Engineered T Cells Sales by Manufacturers
        3.1.1 Engineered T Cells Sales by Manufacturers
        3.1.2 Engineered T Cells Sales Market Share by Manufacturers
        3.1.3 Global Engineered T Cells Market Concentration Ratio (CR5 and HHI)
    3.2 Engineered T Cells Revenue by Manufacturers
        3.2.1 Engineered T Cells Revenue by Manufacturers (2014-2019)
        3.2.2 Engineered T Cells Revenue Share by Manufacturers (2014-2019)
    3.3 Engineered T Cells Price by Manufacturers
    3.4 Engineered T Cells Manufacturing Base Distribution, Product Types
        3.4.1 Engineered T Cells Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Engineered T Cells Product Type
        3.4.3 Date of International Manufacturers Enter into Engineered T Cells  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Engineered T Cells Sales by Product
    4.2 Global Engineered T Cells Revenue by Product
    4.3 Engineered T Cells Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Engineered T Cells Breakdown Data by End User

6 North America
    6.1 North America Engineered T Cells by Countries
        6.1.1 North America Engineered T Cells Sales by Countries
        6.1.2 North America Engineered T Cells Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Engineered T Cells by Product
    6.3 North America Engineered T Cells by End User

7 Europe
    7.1 Europe Engineered T Cells by Countries
        7.1.1 Europe Engineered T Cells Sales by Countries
        7.1.2 Europe Engineered T Cells Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Engineered T Cells by Product
    7.3 Europe Engineered T Cells by End User

8 Asia Pacific
    8.1 Asia Pacific Engineered T Cells by Countries
        8.1.1 Asia Pacific Engineered T Cells Sales by Countries
        8.1.2 Asia Pacific Engineered T Cells Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Engineered T Cells by Product
    8.3 Asia Pacific Engineered T Cells by End User

9 Central & South America
    9.1 Central & South America Engineered T Cells by Countries
        9.1.1 Central & South America Engineered T Cells Sales by Countries
        9.1.2 Central & South America Engineered T Cells Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Engineered T Cells by Product
    9.3 Central & South America Engineered T Cells by End User

10 Middle East and Africa
    10.1 Middle East and Africa Engineered T Cells by Countries
        10.1.1 Middle East and Africa Engineered T Cells Sales by Countries
        10.1.2 Middle East and Africa Engineered T Cells Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Engineered T Cells by Product
    10.3 Middle East and Africa Engineered T Cells by End User

11 Company Profiles
    11.1 Autolus Limited
        11.1.1 Autolus Limited Company Details
        11.1.2 Company Business Overview
        11.1.3 Autolus Limited Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Autolus Limited Engineered T Cells Products Offered
        11.1.5 Autolus Limited Recent Development
    11.2 Bellicum Pharmaceuticals
        11.2.1 Bellicum Pharmaceuticals Company Details
        11.2.2 Company Business Overview
        11.2.3 Bellicum Pharmaceuticals Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Bellicum Pharmaceuticals Engineered T Cells Products Offered
        11.2.5 Bellicum Pharmaceuticals Recent Development
    11.3 Cells Medica
        11.3.1 Cells Medica Company Details
        11.3.2 Company Business Overview
        11.3.3 Cells Medica Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Cells Medica Engineered T Cells Products Offered
        11.3.5 Cells Medica Recent Development
    11.4 Elli Lilly and Company
        11.4.1 Elli Lilly and Company Company Details
        11.4.2 Company Business Overview
        11.4.3 Elli Lilly and Company Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Elli Lilly and Company Engineered T Cells Products Offered
        11.4.5 Elli Lilly and Company Recent Development
    11.5 Gilead Sciences
        11.5.1 Gilead Sciences Company Details
        11.5.2 Company Business Overview
        11.5.3 Gilead Sciences Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Gilead Sciences Engineered T Cells Products Offered
        11.5.5 Gilead Sciences Recent Development
    11.6 Juno Therapeutics
        11.6.1 Juno Therapeutics Company Details
        11.6.2 Company Business Overview
        11.6.3 Juno Therapeutics Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Juno Therapeutics Engineered T Cells Products Offered
        11.6.5 Juno Therapeutics Recent Development
    11.7 Novartis
        11.7.1 Novartis Company Details
        11.7.2 Company Business Overview
        11.7.3 Novartis Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Novartis Engineered T Cells Products Offered
        11.7.5 Novartis Recent Development
    11.8 Oxford Biomedica
        11.8.1 Oxford Biomedica Company Details
        11.8.2 Company Business Overview
        11.8.3 Oxford Biomedica Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Oxford Biomedica Engineered T Cells Products Offered
        11.8.5 Oxford Biomedica Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Company Business Overview
        11.9.3 Pfizer Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Pfizer Engineered T Cells Products Offered
        11.9.5 Pfizer Recent Development
    11.10 Precision Bioscience
        11.10.1 Precision Bioscience Company Details
        11.10.2 Company Business Overview
        11.10.3 Precision Bioscience Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 Precision Bioscience Engineered T Cells Products Offered
        11.10.5 Precision Bioscience Recent Development
    11.11 Redmile Group
    11.12 Seeking Alpha
    11.13 Unum Therapeutics

12 Future Forecast
    12.1 Engineered T Cells Market Forecast by Regions
        12.1.1 Global Engineered T Cells Sales Forecast by Regions 2019-2025
        12.1.2 Global Engineered T Cells Revenue Forecast by Regions 2019-2025
    12.2 Engineered T Cells Market Forecast by Product
        12.2.1 Global Engineered T Cells Sales Forecast by Product 2019-2025
        12.2.2 Global Engineered T Cells Revenue Forecast by Product 2019-2025
    12.3 Engineered T Cells Market Forecast by End User
    12.4 North America Engineered T Cells Forecast
    12.5 Europe Engineered T Cells Forecast
    12.6 Asia Pacific Engineered T Cells Forecast
    12.7 Central & South America Engineered T Cells Forecast
    12.8 Middle East and Africa Engineered T Cells Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Engineered T Cells Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Figures, Tables and Charts Available in Global Engineered T Cells Market Insights, Forecast to 2025

List of Tables and Figures

    Figure Engineered T Cells Product Picture
    Table Engineered T Cells Market Segments
    Table Key Manufacturers Engineered T Cells Covered
    Table Global Engineered T Cells Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Engineered T Cells Sales Market Share by Product 2014-2025
    Figure Tumor Infiltrating Lymphocytes Product Picture
    Table Major Manufacturers of Tumor Infiltrating Lymphocytes
    Figure T Cell Receptor {TCR} Product Picture
    Table Major Manufacturers of T Cell Receptor {TCR}
    Figure Chimeric Antigen Receptor (CAR) Product Picture
    Table Major Manufacturers of Chimeric Antigen Receptor (CAR)
    Table Global Engineered T Cells Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Hospitals
    Figure Cancer Research Centers
    Figure Clinics
    Figure Engineered T Cells Report Years Considered
    Figure Global Engineered T Cells Market Size 2014-2025 (Million US$)
    Figure Global Engineered T Cells Sales 2014-2025 (K Units)
    Table Global Engineered T Cells Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Engineered T Cells Sales by Regions 2014-2019 (K Units)
    Table Global Engineered T Cells Sales Market Share by Regions 2014-2019
    Figure Global Engineered T Cells Sales Market Share by Regions 2014-2019
    Figure 2018 Global Engineered T Cells Sales Market Share by Regions
    Table Global Engineered T Cells Revenue by Regions 2014-2019 (Million US$)
    Table Global Engineered T Cells Revenue Market Share by Regions 2014-2019
    Figure Global Engineered T Cells Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Engineered T Cells Revenue Market Share by Regions
    Table Global Engineered T Cells Sales by Manufacturers (2014-2019) (K Units)
    Table Global Engineered T Cells Sales Share by Manufacturers (2014-2019)
    Figure Global Engineered T Cells Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Engineered T Cells Revenue by Manufacturers (2014-2019) (Million USD)
    Table Engineered T Cells Revenue Share by Manufacturers (2014-2019)
    Figure Engineered T Cells Value Share by Manufacturers in 2018
    Table Key Manufacturers Engineered T Cells Price (2014-2019) (USD/Unit)
    Table Engineered T Cells Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Engineered T Cells Product Type
    Table Date of International Manufacturers Enter into Engineered T Cells Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Engineered T Cells Sales by Product (2014-2019) (K Units)
    Table Global Engineered T Cells Sales Share by Product (2014-2019)
    Figure Global Engineered T Cells Sales Market Share by Product (2014-2019)
    Figure Global Engineered T Cells Sales Market Share by Product in 2018
    Table Global Engineered T Cells Revenue by Product (2014-2019) (Million US$)
    Table Global Engineered T Cells Revenue Share by Product (2014-2019)
    Figure Global Engineered T Cells Revenue Market Share by Product (2014-2019)
    Figure Global Engineered T Cells Revenue Market Share by Product in 2018
    Table Engineered T Cells Price by Product 2014-2019 (USD/Unit)
    Table Global Engineered T Cells Sales by End User (2014-2019) (K Units)
    Table Global Engineered T Cells Sales Share by End User (2014-2019)
    Figure Global Sales Engineered T Cells Market Share by End User (2014-2019)
    Figure Global Sales Engineered T Cells Market Share by End User in 2018
    Figure North America Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
    Figure North America Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Engineered T Cells Sales by Countries (2014-2019) (K Units)
    Table North America Engineered T Cells Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Engineered T Cells Sales Market Share by Countries
    Table North America Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
    Table North America Engineered T Cells Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Engineered T Cells Revenue Market Share by Countries
    Figure United States Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure United States Engineered T Cells Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Engineered T Cells Sales by Product (2014-2019) (K Units)
    Table North America Engineered T Cells Sales Market Share by Product (2014-2019)
    Figure 2018 North America Engineered T Cells Market Share by Product
    Table North America Engineered T Cells Sales by End User (2014-2019) (K Units)
    Table North America Engineered T Cells Sales Market Share by End User (2014-2019)
    Figure 2018 North America Engineered T Cells Market Share by End User
    Figure Europe Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Engineered T Cells Sales by Countries (2014-2019) (K Units)
    Table Europe Engineered T Cells Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Engineered T Cells Sales Market Share by Countries
    Table Europe Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
    Table Europe Engineered T Cells Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Engineered T Cells Revenue Market Share by Countries
    Figure Germany Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure France Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure UK Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Engineered T Cells Sales by Product (2014-2019) (K Units)
    Table Europe Engineered T Cells Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Engineered T Cells Market Share by Product
    Table Europe Engineered T Cells Sales by End User (2014-2019) (K Units)
    Table Europe Engineered T Cells Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Engineered T Cells Market Share by End User
    Figure Asia Pacific Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Engineered T Cells Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Engineered T Cells Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Engineered T Cells Sales Market Share by Countries
    Table Asia Pacific Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Engineered T Cells Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Engineered T Cells Revenue Market Share by Countries
    Figure China Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure China Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure India Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Engineered T Cells Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Engineered T Cells Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Engineered T Cells Market Share by Product
    Table Asia Pacific Engineered T Cells Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Engineered T Cells Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Engineered T Cells Market Share by End User
    Figure Central & South America Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Engineered T Cells Sales by Countries (2014-2019) (K Units)
    Table Central & South America Engineered T Cells Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Engineered T Cells Sales Market Share by Countries
    Table Central & South America Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Engineered T Cells Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Engineered T Cells Revenue Market Share by Countries
    Figure Brazil Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Engineered T Cells Sales by Product (2014-2019) (K Units)
    Table Central & South America Engineered T Cells Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Engineered T Cells Market Share by Product
    Table Central & South America Engineered T Cells Sales by End User (2014-2019) (K Units)
    Table Central & South America Engineered T Cells Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Engineered T Cells Market Share by End User
    Figure Middle East and Africa Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Engineered T Cells Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Engineered T Cells Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Engineered T Cells Sales Market Share by Countries
    Table Middle East and Africa Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Engineered T Cells Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Engineered T Cells Revenue Market Share by Countries
    Figure GCC Countries Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Engineered T Cells Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Engineered T Cells Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Engineered T Cells Market Share by Product
    Table Middle East and Africa Engineered T Cells Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Engineered T Cells Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Engineered T Cells Market Share by End User
    Table Autolus Limited Company Details
    Table Autolus Limited Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Autolus Limited Recent Development

    Table Bellicum Pharmaceuticals Company Details
    Table Bellicum Pharmaceuticals Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Bellicum Pharmaceuticals Recent Development

    Table Cells Medica Company Details
    Table Cells Medica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Cells Medica Recent Development

    Table Elli Lilly and Company Company Details
    Table Elli Lilly and Company Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Elli Lilly and Company Recent Development

    Table Gilead Sciences Company Details
    Table Gilead Sciences Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Gilead Sciences Recent Development

    Table Juno Therapeutics Company Details
    Table Juno Therapeutics Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Juno Therapeutics Recent Development

    Table Novartis Company Details
    Table Novartis Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Novartis Recent Development

    Table Oxford Biomedica Company Details
    Table Oxford Biomedica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Oxford Biomedica Recent Development

    Table Pfizer Company Details
    Table Pfizer Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Pfizer Recent Development

    Table Precision Bioscience Company Details
    Table Precision Bioscience Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Precision Bioscience Recent Development

    Table Redmile Group Company Details
    Table Seeking Alpha Company Details
    Table Unum Therapeutics Company Details
    Table Global Engineered T Cells Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Engineered T Cells Sales Market Share Forecast by Regions 2019-2025
    Table Global Engineered T Cells Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Engineered T Cells Revenue Market Share Forecast by Regions 2019-2025
    Table Global Engineered T Cells Sales Forecast by Product 2019-2025 (K Units)
    Table Global Engineered T Cells Sales Market Share Forecast by Product 2019-2025
    Table Global Engineered T Cells Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Engineered T Cells Revenue Market Share Forecast by Product 2019-2025
    Table Global Engineered T Cells Sales Forecast by End User 2019-2025 (K Units)
    Table Global Engineered T Cells Sales Market Share Forecast by End User 2019-2025
    Figure North America Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Engineered T Cells Value Chain
    Table Engineered T Cells Customers List
    Table Engineered T Cells Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Keyplayers in Global Engineered T Cells Market Insights, Forecast to 2025

Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics